Busca avançada
Ano de início
Entree


Higher Incidence of Lung Adenocarcinomas Induced by DMBA in Connexin 43 Heterozygous Knockout Mice

Texto completo
Autor(es):
de Oliveira, Krishna Duro ; Tedardi, Marcello Vannucci ; Cogliati, Bruno ; Zaidan Dagli, Maria Lucia
Número total de Autores: 4
Tipo de documento: Artigo Científico
Fonte: BIOMED RESEARCH INTERNATIONAL; v. 2013, p. 6-pg., 2013-01-01.
Resumo

Gap junctions are communicating junctions which are important for tissue homeostasis, and their disruption is involved in carcinogenic processes. This study aimed to verify the influence of deletion of one allele of the Connexin 43 gene on cancer incidence in different organs. The 7,12-dimethylbenzanthracene (DMBA) carcinogenic model, using hebdomadary doses by gavage of 9 mg per animal, was used to induce tumors in Connexin 43 heterozygous or wild-type mice. The experiment began in the eighth week of the mice life, and all of them were euthanized when reaching inadequate physical condition, or at the end of 53 weeks. No statistical differences occurred for weight gain and cancer survival time (P = 0.9853) between heterozygous and wild-type mice. Cx43(+/-) mice presented significantly higher susceptibility to lung cancer (P = 0.0200) which was not evidenced for benign neoplasms (P = 0.3449). In addition, incidence of ovarian neoplasms was 2.5-fold higher in Cx43(+/-) mice, although not statistically significant. Other organs showed a very similar cancer occurrence between Cx43 groups. The experiment strengthens the evidence of the relationship between Connexin 43 deficiency and carcinogenesis. (AU)

Processo FAPESP: 10/08480-3 - Carcinogênese mamária induzida por DMBA em camundongos geneticamente modificados, deficientes em conexina 43
Beneficiário:Maria Lucia Zaidan Dagli
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 10/00874-2 - Avaliação da expressão de receptores de estrógeno e progesterona, E-caderina, citoqueratinas 5 e 14, vimentina, c-kit, PCNA e PTEN em neoplasias mamárias induzidas em camundongos Balb/c por 7,12-dimetilbenzantraceno (DMBA)
Beneficiário:Marcello Vannucci Tedardi
Modalidade de apoio: Bolsas no Brasil - Iniciação Científica